Centene Corporation ( CNC ), a giant of managed care expected to cross $175 billion in revenues this year, unexpectedly pulled its earnings guidance for 2025 on July 2. This change came after an unexpected shift in the dynamics of the health Insurance Marketplace, which could impact earnings more significantly than what was initially forecasted.
CNC's Q2 earnings are likely to have felt the pinch as rising medical costs pressure margins despite higher premium revenues.
Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Medical - Healthcare Plans Industry | Healthcare Sector | Sarah M. London CEO | LSE Exchange | GB0002183191 ISIN |
US Country | 60,400 Employees | - Last Dividend | 7 Feb 2019 Last Split | 13 Dec 2001 IPO Date |
Centene Corporation stands as a prominent healthcare enterprise catering to the essential healthcare needs of under-insured and uninsured families, commercial organizations, and military families within the United States. Distinguished by its commitment to providing comprehensive health programs and services, the company navigates through the complexity of healthcare needs across diverse populations. Established in 1984 and headquartered in Saint Louis, Missouri, Centene has carved a niche for itself in the healthcare sector by offering a wide array of services across its multiple operational segments including Medicaid, Medicare, Commercial, and Other segments. The company's focus on accessibility and quality care underlines its mission to deliver healthcare solutions that foster well-being and improve health outcomes for all its members.
Centene's product and service portfolio spans across several key areas of healthcare, addressing the needs of a vast demographic through its diversified offerings: